Three scientists share 2026 Nobel Prize in medicine for inventing optogenetics

STOCKHOLM — The Nobel Assembly at the Karolinska Institutet on Monday awarded the 2026 Nobel Prize in Physiology or Medicine to three scientists credited with giving neuroscience one of its most powerful modern tools: a way to switch individual nerve cells on and off using pulses of light. The official citation honors Karl Deisseroth, 54, of Stanford University; Peter Hegemann, 71, of Humboldt University of Berlin; and Georg Nagel, 73, of the University of Würzburg, "for their discoveries concerning light-gated ion channels and optogenetics."

The announcement, made at the Nobel Forum in Solna shortly before noon local time, opened this year's Nobel season, with the physics prize following on Tuesday and the chemistry, literature and peace prizes to be named through the rest of the week. It is the first Nobel recognition for optogenetics, a technique that has become routine in neuroscience laboratories on every continent since its development roughly two decades ago, letting researchers trigger or silence specific neurons in living tissue and observe the behavioral consequences in real time.

The prize, by the numbers

The award carries a cash prize of 12 million Swedish kronor, roughly $1.2 million, to be split evenly among the three laureates. According to the Nobel Foundation's own tally of past medicine laureates, the trio joins a list of fewer than 240 people to receive the physiology or medicine prize since it was first given in 1901, on which women remain a small minority. A three-way split, as happened this year, has now occurred more than forty times in the prize's history. Deisseroth is also a Howard Hughes Medical Institute investigator, a role noted on his Stanford faculty profile, while Hegemann and Nagel have spent much of their careers in German university biophysics departments.

Details of this week's remaining announcements are listed on the Nobel Foundation's 2026 announcement calendar, which confirms Monday's medicine prize as the first of the week.

How a pond alga led to a Nobel Prize

The discovery traces back to a basic biological puzzle: why can a single-celled green alga called Chlamydomonas swim toward light? Working largely independently in the early 1990s and then together, Hegemann and Nagel identified the protein responsible, a light-sensitive channel in the cell membrane that snaps open the instant it is struck by light, a molecule now known as channelrhodopsin, as STAT News reported in its account of the prize.

Deisseroth's contribution came roughly a decade later, when his Stanford laboratory inserted the gene for channelrhodopsin into mammalian neurons and showed that shining blue light on those cells could trigger them to fire with millisecond precision, fast enough to match the brain's own electrical signaling. That combination, a genetically targeted light-sensitive switch paired with the ability to deliver pulses of light into living brain tissue, became the method now called optogenetics. It let scientists, for the first time, isolate the activity of one defined set of neurons from everything else happening in a living brain and watch what changed in an animal's behavior when those cells were turned on or off.

The method spread quickly after Deisseroth's lab and collaborators published their results in the mid-2000s and is now standard laboratory practice, according to NBC News's report on the announcement, which quoted the Nobel Assembly's own statement that the technique "is now being used in laboratories around the world to reveal the brain's mysteries."

Who stands to benefit

The most immediate beneficiaries are the thousands of neuroscience laboratories that already rely on optogenetic tools to study memory, movement, fear, addiction and sleep by mapping which clusters of neurons drive which behaviors in laboratory animals. That basic-science payoff is why the Nobel committee grouped the discovery with other tool-building prizes in the medicine category's history, alongside methods such as PCR and CRISPR gene editing that reshaped entire fields rather than solving one disease.

There is also a slower, more direct line to patients. Al Jazeera's coverage of the Stockholm announcement quoted Thomas Perlmann, the Nobel Assembly's secretary-general, describing the method as one that "makes it possible to switch on, or off, the activity of individual nerve cells in a living brain," and noted that researchers are exploring whether the same light-based precision could sharpen devices such as cochlear implants. University of Würzburg materials on Nagel's research describe related work aimed at restoring vision lost to retinal disease and easing symptoms of Parkinson's disease by activating surviving neurons with implanted light sources. Those applications remain in early research and trial stages rather than approved treatments, but they mark the clearest path by which Monday's prize could eventually reach patients with inherited blindness or movement disorders who have few other options.

"Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of," said Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, announcing the award in Stockholm.

What comes next

Deisseroth, speaking after the announcement, described the core appeal of the method in plain terms, saying researchers are "using light to turn cells on or off with that millisecond precision and the cellular resolution that is essential to brain function," in remarks reported by STAT. Deisseroth and Hegemann had already shared the 2021 Lasker Basic Medical Research Award for related work, one reason the Nobel had been widely expected inside the field eventually, even if the exact timing was not.

The Nobel calendar now moves to physics on Tuesday, followed by chemistry on Wednesday, literature on Thursday and the Peace Prize on Friday from Oslo, with the economics prize closing out next week. All three medicine laureates are expected to travel to Stockholm in December for Nobel Week, which culminates in the formal prize ceremony held each year on December 10, the anniversary of Alfred Nobel's death, where they will receive their medals, diplomas and the shared monetary award from the Swedish king. In the meantime, the practical legacy of their work will keep accumulating quietly in laboratories that had already folded optogenetics into everyday experiments long before Monday's announcement, which mainly confirmed what many in the field already believed: that flipping neurons on and off with light had changed how the brain is studied for good.